Long-term effects of birth order and age at diagnosis in cystic fibrosis: A sibling cohort study

Pediatric Pulmonology

Volumn 45, Issue 6, 2010, Pages 601-607

  Slieker, M G ^a   Van Den Berg, J M W ^b   Kouwenberg, J ^b   Van Berkhout, F Teding ^a   Heijerman, H G M ^b   Van Der Ent, C K ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

Cystic fibrosis; Lung function; Prognosis; Pseudomonas aeruginosa; Siblings

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BIRTH ORDER; COHORT ANALYSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENOTYPE; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PNEUMOTACHYGRAPHY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SIBLING; SURVIVAL;

ADOLESCENT; AGE OF ONSET; BIRTH ORDER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; NETHERLANDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SIBLINGS; TIME; YOUNG ADULT;

EID: 77953309870     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21227     Document Type: Article

References (37)

1. Mckone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest 2006;130:1441-1447.
2. Schechter MS. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med 2003;24:639-652.
3. Knowles MR. Gene modifiers of lung disease. Curr Opin Pulm Med 2006;12:416-421.
4. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K, Algire M, McWilliams R, Beck S, Hoover-Fong J, Hamosh A, Cutler D, Cutting GR. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 2007;175:1036-1043.
5. Picard E, Aviram M, Yahav Y, Rivlin J, Blau H, Bentur L, Avital A, Villa Y, Schwartz S, Kerem B, Kerem E. Familial concordance of phenotype and microbial variation among siblings with CF. Pediatr Pulmonol 2004;38:292-297.
6. Katz SL, Strug LJ, Coates AL, Corey M. Disease severity in siblings with cystic fibrosis. Pediatr Pulmonol 2004;37:407-412.
7. McKay KO, Waters DL, Gaskin KJ. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales. J Pediatr 2005;147:S47-S50.
8. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 2001;18:306-315.
9. Mastella G, Zanolla L, Castellani C, Altieri S, Furnari M, Giglio L, Lombardo M, Miano A, Sciuto C, Pardo F, Magazzu G. Neonatal screening for cystic fibrosis: long-term clinical balance. Pancreatology 2001;1:531-537.
10. Wang SS, O'Leary LA, Fitzsimmons SC, Khoury MJ. The impact of early cystic fibrosis diagnosis on pulmonary function in children. J Pediatr 2002;141:804-810.
11. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001;107:1-13.
12. Sims EJ, McCormick J, Mehta G, Mehta A. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment. J Pediatr 2005;147:S42-S46. (Pubitemid 41400258)
13. Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns / SNM> WT, Splaingard M, Mischler EH. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 1997;337:963-969.
14. Siret D, Bretaudeau G, Branger B, Dabadie A, Dagorne M, David V, De Braekeleer M, Moisan-Petit V, Picherot G, Rault G, Storni V, Roussey M. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 2003;35:342-349.
15. Doull IJ, Ryley HC, Weller P, Goodchild MC. Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatr Pulmonol 2001;31:363-366.
16. Lai HJ, Cheng Y, Farrell PM. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data. J Pediatr 2005;147:S57-S63.
17. Tubbs D, Lenney W, Alcock P, Campbell CA, Gray J, Pantin C. Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation. Respir Med 2001;95:147-152.
18. Renders NH, Sijmons MA, van BA, Overbeek SE, Mouton JW, Verbrugh HA. Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol 1997;148:447-454.
19. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100.
20. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704.
21. van der Laag J, Sinaasappel M, Heijerman HGM, editors. Diagnostiek en behandeling van cystic fibrosis [Diagnosis and treatment of cystic fibrosis]. Utrecht: Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing; 1998. 174 p.
22. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods, reference values. In: Zapletal A, Samanek M, Paul T, editors. Progress in respiration research. Basel, Switzerland: Karger; 1987. pp 114-218.
23. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur Respir J 1993;16:5-40.
24. TNO Prevention and Health, Leiden University Medical Center. Growth diagrams 1997. 1998. Houten, the Netherlands: Bohn Stafleu Van Loghum.
25. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003;2:29-34.
26. Doring G, Conway SP, Heijerman HG, Hodson ME, Hoiby N, Smyth A, Touw DJ. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000;16:749-767.
27. Vankeerberghen A, Cuppens H, Cassiman JJ. The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst Fibros 2002;1:13-29.
28. Mckone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003;361:1671-1676.
29. Waters DL, Wilcken B, Irwing L, Van Asperen P, Mellis C, Simpson JM, Brown J, Gaskin KJ. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999;80:F1-F7. (Pubitemid 29129589)
30. Orenstein DM, Boat TF, Stern RC, Tucker AS, Charnock EL, Matthews LW, Doershuk CF. The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of 16 sibling pairs. Am J Dis Child 1977;131:973-975.
31. Thomassen MJ, Demko CA, Doershuk CF, Root JM. Pseudomonas aeruginosa isolates: comparisons of isolates from campers and from sibling pairs with cystic fibrosis. Pediatr Pulmonol 1985;1:40-45.
32. Baussano I, Tardivo I, Bellezza-Fontana R, Forneris MP, Lezo A, Anfossi L, Castello M, Aleksandar V, Bignamini E. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Pediatrics 2006;118:888-895.
33. Collins MS, Abbott MA, Wakefield DB, Lapin CD, Drapeau G, Hopfer SM, Greenstein RM, Cloutier MM. Improved pulmonary and growth outcomes in cystic fibrosis by newborn screening. Pediatr Pulmonol 2008;43:648-655.
34. Proesmans M, Balinska-Miskiewicz W, Dupont L, Bossuyt X, Verhaegen J, Hoiby N, De BK. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006;27:937-943.
35. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995;50:712-718.
36. Lebecque P, Leonard A, De BK, De BF, Malfroot A, Casimir G, Desager K, Godding V, Leal T. Early referral to cystic fibrosis specialist centre impacts on respiratory outcome. J Cyst Fibros 2009;8:26-30.
37. Slieker MG, Uiterwaal CSPM, Sinaasappel M, Heijerman HGM, van der Laag J, van der Ent CK. Birth prevalence and survival in cystic fibrosis - a national cohort study in the Netherlands. Chest 2005;128:2309-2315.